10-116861137-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001242699.2(ENO4):āc.883A>Cā(p.Asn295His) variant causes a missense change. The variant allele was found at a frequency of 0.00000388 in 1,547,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 30)
Exomes š: 0.0000036 ( 0 hom. )
Consequence
ENO4
NM_001242699.2 missense
NM_001242699.2 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 4.60
Genes affected
ENO4 (HGNC:31670): (enolase 4) Predicted to enable phosphopyruvate hydratase activity. Predicted to be involved in glycolytic process and regulation of vacuole fusion, non-autophagic. Predicted to act upstream of or within cilium organization and flagellated sperm motility. Predicted to be located in sperm principal piece. Predicted to be part of phosphopyruvate hydratase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13205332).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENO4 | NM_001242699.2 | c.883A>C | p.Asn295His | missense_variant | 6/14 | ENST00000341276.11 | NP_001229628.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENO4 | ENST00000341276.11 | c.883A>C | p.Asn295His | missense_variant | 6/14 | 5 | NM_001242699.2 | ENSP00000345555 | P1 | |
ENO4 | ENST00000409522.5 | c.166-7513A>C | intron_variant | 1 | ENSP00000387194 | |||||
ENO4 | ENST00000369207.3 | c.355A>C | p.Asn119His | missense_variant | 3/11 | 5 | ENSP00000358208 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151814Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
1
AN:
151814
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000269 AC: 4AN: 148780Hom.: 0 AF XY: 0.0000125 AC XY: 1AN XY: 80174
GnomAD3 exomes
AF:
AC:
4
AN:
148780
Hom.:
AF XY:
AC XY:
1
AN XY:
80174
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000358 AC: 5AN: 1395446Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 688434
GnomAD4 exome
AF:
AC:
5
AN:
1395446
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
688434
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151922Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74258
GnomAD4 genome
AF:
AC:
1
AN:
151922
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
74258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2024 | The c.883A>C (p.N295H) alteration is located in exon 6 (coding exon 6) of the ENO4 gene. This alteration results from a A to C substitution at nucleotide position 883, causing the asparagine (N) at amino acid position 295 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;N;N
PrimateAI
Benign
T
PROVEAN
Benign
.;.;N
REVEL
Benign
Sift
Benign
.;.;T
Sift4G
Benign
T;T;T
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at